HOUSTON: Axovant Sciences (NASDAQ:AXON)‘s stock had its “sell” rating reiterated by stock analysts at Chardan Capital in a research report issued to clients and investors.

The company’s stock had a trading volume of 626,746 shares. Axovant Sciences has a 52-week low of $12.75 and a Read More »

LOS ANGELES: Google’s secretive Calico operation, founded in 2013, is putting hundreds of millions of dollars into anti-aging research.

Craig Venter, the genetics entrepreneur, has launched a company called Human Longevity to find the genes that lead to long life. Meanwhile, scientists have asked the US Read More »

WASHINGTON, D.C.: A new study suggests commonly used first-line treatments for PTSD in veterans may not work as well as medical experts once thought.

The number of veterans who suffer from PTSD continues to be a serious national public health problem. Recent data show that more Read More »

HOUSTON: Innovation has always been the blood pumping through the body of the pharmaceutical industry, but in recent years the supply seemed to be getting poorer.

Yet now a slew of breakthroughs in treatment for diseases like Hepatitis C, Ebola, malaria and even Alzheimer’s, the Read More »